Bioter S.A. Announced earnings results for the full year ended December 31, 2020. For the full year, the company announced sales was EUR 228,000 compared to EUR 250,000 a year ago. Net income was EUR 5.954 million compared to net loss of EUR 8.891 million a year ago. Basic earnings per share from continuing operations was EUR 0.3537 compared to basic loss per share from continuing operations of EUR 0.5368 a year ago. Diluted earnings per share from continuing operations was EUR 0.354 compared to diluted loss per share from continuing operations of EUR 0.537 a year ago.